T1DM or T2DM – Insulin Dependent
Post Approval Study for Non-Adjunctive Use of Dexcom G5® CGM System for Diabetes Management
Continous Monitoring And Control of Hypoglycemia
Study Length: 1 Year
Target Age/Sex: Adults and pediatrics (2 or older), naïve to CGM, with Type 1 or insulin-requiring Type 2 diabetes
Participants will receive 6 months free use of the Dexcom G5 CGM system and all supplies, study related lab work. Subject will also receive a stipend for time/travel related to the study.